Informe completo: Stool DNA testing for colorectal cancer (CRC) screening
Objetivo: Multi-target stool DNA (MT-sDNA) testing is a novel non-invasive screening test that may be able to supplement or replace established stool tests by analysing (stool-based) tumour DNA. In this policy brief, the latest available evidence with regard to the clinical benefits and harms of MT-sDNA tests is summarised.
Recomendación: More high quality evidence derived from randomised controlled trials is needed to clearly show whether a screening.
Autoría: Austrian Institute for Health Technology Assessment (AIHTA)
Año de publicación: 2021